This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
WASHINGTON — Doctors will get a 1.68% pay hike in Medicare starting March 9 under a deal struck over the weekend to fund part of the government. The pay bump is among multiple Medicare payment policies that now will run until the end of December. That year-end deadline lines up with the expiration of telehealth pay policies , setting the stage for a large health legislative package and giving Congress another shot at aligning hospital and doctor office payments and reforming the business
By Steven J. Gonzalez & JP Ellison — The most recent version of the BIOSECURE Act (the “Act”) was introduced in the U.S. House of Representatives ( H.B. 7085 ) and Senate ( S.B. 3558 ) on January 25, 2024. This proposed legislation should be of interest to any biotechnology companies that want to do business with the federal government in the future.
Avidity Biosciences files $400m private placement as it prepares for phase 3 trial of lead antibody oligonucleotide conjugate AOC 1001 in rare disease DM1
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
March is malignant hyperthermia awareness and training month and at OctariusRx, we are always focused on patient safety. Join us this month as we raise awareness and support the cause. Malignant hyperthermia (MH) is a rare, inherited disorder that can affect patients who are receiving anesthesia for surgery or other procedures. Being prepared is paramount for patient safety.
By Jeffrey N. Gibbs & Allyson B. Mullen — FDA’s proposed rule to regulate laboratory developed tests (LDTs) as devices took one more step towards being finalized – and to a likely judicial showdown. On March 1, the Office of Management and Budget (OMB) received the draft final LDT rule for review ( here ). The LDT rule has moved forward with astonishing speed, advancing from the release of the proposed rule on October 3, 2023 to OMB in less than five months.
Presented by BetterHelp. Some people still aren’t aware that men and non-gestational parents can also experience emotional dysregulation after the birth of a child. Luckily, the conversation surrounding women and gestational parents and postpartum depression has gained a lot of awareness. However, are we forgetting the other half of the parenting dyad?
Blood pressure medications are commonly used in practice. You should know some of the major interactions with these medications. In this blog post, I will lay out my top 5 antihypertensive drug interactions and also share some information on how these interactions can affect our patients. Hyperkalemia Risk ACEIs and ARBs are atop the list […] The post Top 5 Antihypertensive Drug Interactions appeared first on Med Ed 101.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content